Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Suicide, other externally caused injuries and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan (J-SUPPORT 1902).

Harashima S, Fujimori M, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ.

BMJ Open. 2019 Jul 4;9(7):e030681. doi: 10.1136/bmjopen-2019-030681.

2.

gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.

Easmin F, Hassan N, Sasano Y, Ekino K, Taguchi H, Harashima S.

J Biosci Bioeng. 2019 Sep;128(3):373-378. doi: 10.1016/j.jbiosc.2019.02.009. Epub 2019 Apr 19.

PMID:
31010727
3.

Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: A retrospective cohort study.

Oshima A, Nishimura A, Chen-Yoshikawa TF, Harashima SI, Komatsu T, Handa T, Aoyama A, Takahashi K, Ikeda M, Oshima Y, Ikezoe K, Sato S, Isomi M, Shide K, Date H, Inagaki N.

Clin Transplant. 2019 Jun;33(6):e13566. doi: 10.1111/ctr.13566. Epub 2019 May 12.

PMID:
31002178
4.

Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study.

Nishimura A, Harashima SI, Hosoda K, Arai H, Inagaki N.

Ther Adv Endocrinol Metab. 2019 Mar 5;10:2042018819833304. doi: 10.1177/2042018819833304. eCollection 2019.

5.

Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.

Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N.

FASEB J. 2019 May;33(5):6239-6253. doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21.

PMID:
30789757
6.

Genetic analysis of suppressor mutants of a pho84 disruptant in the search for genes involved in intracellular inorganic phosphate sensing in Saccharomyces cerevisiae.

Sasano Y, Sakata T, Okusaki S, Sugiyama M, Kaneko Y, Harashima S.

Genes Genet Syst. 2018 Dec 22;93(5):199-207. doi: 10.1266/ggs.18-00014. Epub 2018 Nov 16.

7.

Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.

Harashima S, Yoneda R, Horie T, Fujioka Y, Nakamura F, Kurokawa M, Yoshiuchi K.

Bone Marrow Transplant. 2019 Jul;54(7):1013-1021. doi: 10.1038/s41409-018-0371-6. Epub 2018 Oct 23.

PMID:
30353064
8.

Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study.

Nishimura A, Harashima SI, Hosoda K, Inagaki N.

Diabetes Ther. 2018 Aug;9(4):1501-1510. doi: 10.1007/s13300-018-0457-6. Epub 2018 Jun 12.

9.

Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients.

Inagaki N, Harashima SI, Iijima H.

Expert Opin Pharmacother. 2018 Jun;19(8):895-908. doi: 10.1080/14656566.2018.1473378. Epub 2018 May 25.

PMID:
29799286
10.

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study.

Harashima SI, Inagaki N, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Watanabe Y.

Diabetes Obes Metab. 2018 Jul;20(7):1770-1775. doi: 10.1111/dom.13267. Epub 2018 Mar 24.

11.

Cross-cultural comparison of predictors for self-care behaviors in patients with type 2 diabetes.

Ikeda K, Fujimoto S, Morling B, Ayano-Takahara S, Harashima SI, Uchida Y, Inagaki N.

J Diabetes Investig. 2018 Sep;9(5):1212-1215. doi: 10.1111/jdi.12822. Epub 2018 Mar 23.

12.

The Effect of Novel Glucose Monitoring System (Flash Glucose Monitoring) on Mental Well-being and Treatment Satisfaction in Japanese People with Diabetes.

Mitsuishi S, Nishimura R, Harashima SI, Kawamura T, Tsujino D, Koide K, Nishimura A, Utsunomiya K, Inagaki N, Atsumi Y.

Adv Ther. 2018 Jan;35(1):72-80. doi: 10.1007/s12325-017-0649-x. Epub 2017 Dec 22.

PMID:
29273859
13.

Longitudinal course of eating disorders after transsexual treatment: a report of two cases.

Hiraide M, Harashima S, Yoneda R, Otani M, Kayano M, Yoshiuchi K.

Biopsychosoc Med. 2017 Dec 17;11:32. doi: 10.1186/s13030-017-0118-4. eCollection 2017.

14.

Whole-exome sequencing in a Japanese family with highly aggregated diabetes identifies a candidate susceptibility mutation in ADAMTSL3.

Jambaljav B, Tanaka D, Nagashima K, Harashima SI, Harada N, Harada T, Fujiwara Y, Wang Y, Liu Y, Tabara Y, Matsuda F, Koizumi A, Inagaki N.

Diabetes Res Clin Pract. 2018 Jan;135:143-149. doi: 10.1016/j.diabres.2017.11.012. Epub 2017 Nov 21.

PMID:
29162515
15.

Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima SI, Kaku K, Kondo K, Maruyama N, Otsuka M, Kawaguchi Y, Iijima H.

Diabetes Obes Metab. 2018 Apr;20(4):812-820. doi: 10.1111/dom.13152. Epub 2017 Dec 5.

16.

Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.

Ikezoe K, Handa T, Tanizawa K, Chen-Yoshikawa TF, Kubo T, Aoyama A, Motoyama H, Hijiya K, Tokuda S, Nakatsuka Y, Yamamoto Y, Oshima A, Harashima SI, Nagai S, Hirai T, Date H, Chin K.

PLoS One. 2017 Aug 11;12(8):e0183171. doi: 10.1371/journal.pone.0183171. eCollection 2017.

17.

Physical activity level significantly affects the survival of patients with end-stage lung disease on a waiting list for lung transplantation.

Komatsu T, Oshima A, Chen-Yoshikawa TF, Harashima SI, Aoyama A, Inagaki N, Date H.

Surg Today. 2017 Dec;47(12):1526-1532. doi: 10.1007/s00595-017-1542-6. Epub 2017 May 24.

PMID:
28540430
18.

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

Yoshiji S, Murakami T, Harashima SI, Ko R, Kashima R, Yabe D, Ogura M, Doi K, Inagaki N.

J Diabetes Investig. 2018 Mar;9(2):445-447. doi: 10.1111/jdi.12695. Epub 2017 Jun 26.

19.

Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion.

Wang Y, Harashima SI, Liu Y, Usui R, Inagaki N.

Sci Rep. 2017 Apr 10;7(1):779. doi: 10.1038/s41598-017-00900-7.

20.

Severe underweight decreases the survival rate in adult lung transplantation.

Komatsu T, Chen-Yoshikawa TF, Oshima A, Harashima SI, Aoyama A, Inagaki N, Date H.

Surg Today. 2017 Oct;47(10):1243-1248. doi: 10.1007/s00595-017-1508-8. Epub 2017 Mar 17.

PMID:
28315009
21.

Development of the Japanese Version of the Psychosocial Assessment of Candidates for Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation.

Harashima S, Yoneda R, Horie T, Kayano M, Fujioka Y, Nakamura F, Kurokawa M, Yoshiuchi K.

Psychosomatics. 2017 May - Jun;58(3):292-298. doi: 10.1016/j.psym.2017.01.006. Epub 2017 Jan 19.

PMID:
28314524
22.

A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.

Nishimura A, Harashima SI, Fukushige H, Wang Y, Liu Y, Hosoda K, Inagaki N.

Diabetes Ther. 2017 Apr;8(2):385-399. doi: 10.1007/s13300-017-0238-7. Epub 2017 Feb 24.

23.

Molecular breeding of Saccharomyces cerevisiae with high RNA content by harnessing essential ribosomal RNA transcription regulator.

Sasano Y, Kariya T, Usugi S, Sugiyama M, Harashima S.

AMB Express. 2017 Dec;7(1):32. doi: 10.1186/s13568-017-0330-4. Epub 2017 Feb 2.

24.

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.

Sorli C, Harashima SI, Tsoukas GM, Unger J, Karsbøl JD, Hansen T, Bain SC.

Lancet Diabetes Endocrinol. 2017 Apr;5(4):251-260. doi: 10.1016/S2213-8587(17)30013-X. Epub 2017 Jan 17.

PMID:
28110911
25.

A series of patients with purging type anorexia nervosa who do "tube vomiting".

Horie T, Harashima S, Yoneda R, Hiraide M, Inada S, Otani M, Yoshiuchi K.

Biopsychosoc Med. 2016 Nov 15;10:32. eCollection 2016.

26.

Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study.

Harashima SI, Nishimura A, Inagaki N.

Expert Opin Pharmacother. 2017 Jan;18(1):5-11. doi: 10.1080/14656566.2016.1260547. Epub 2016 Dec 5.

PMID:
27846737
27.

Cellular mechanisms contributing to multiple stress tolerance in Saccharomyces cerevisiae strains with potential use in high-temperature ethanol fermentation.

Kitichantaropas Y, Boonchird C, Sugiyama M, Kaneko Y, Harashima S, Auesukaree C.

AMB Express. 2016 Dec;6(1):107. doi: 10.1186/s13568-016-0285-x. Epub 2016 Nov 8.

28.

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial.

Nishimura A, Harashima SI, Fujita Y, Tanaka D, Wang Y, Liu Y, Inagaki N.

J Diabetes Complications. 2017 Jan;31(1):228-233. doi: 10.1016/j.jdiacomp.2016.08.019. Epub 2016 Aug 28.

PMID:
27653670
29.

CRISPR-PCS: a powerful new approach to inducing multiple chromosome splitting in Saccharomyces cerevisiae.

Sasano Y, Nagasawa K, Kaboli S, Sugiyama M, Harashima S.

Sci Rep. 2016 Aug 17;6:30278. doi: 10.1038/srep30278.

30.

Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.

Takada S, Masaki Y, Kinugawa S, Matsumoto J, Furihata T, Mizushima W, Kadoguchi T, Fukushima A, Homma T, Takahashi M, Harashima S, Matsushima S, Yokota T, Tanaka S, Okita K, Tsutsui H.

Cardiovasc Res. 2016 Sep;111(4):338-47. doi: 10.1093/cvr/cvw182. Epub 2016 Jul 21.

PMID:
27450980
31.

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima S, Maruyama N, Kawaguchi Y, Goda M, Iijima H.

Cardiovasc Diabetol. 2016 Jun 18;15:89. doi: 10.1186/s12933-016-0407-4.

32.

Overexpression of ESBP6 improves lactic acid resistance and production in Saccharomyces cerevisiae.

Sugiyama M, Akase SP, Nakanishi R, Kaneko Y, Harashima S.

J Biosci Bioeng. 2016 Oct;122(4):415-20. doi: 10.1016/j.jbiosc.2016.03.010. Epub 2016 Apr 18.

PMID:
27102264
33.

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial.

Kondo Y, Harada N, Hamasaki A, Kaneko S, Yasuda K, Ogawa E, Harashima S, Yoneda H, Fujita Y, Kitano N, Nakamura Y, Matsuo F, Shinji M, Hinotsu S, Nakayama T, Inagaki N; MAIKO Study group.

Diabetol Metab Syndr. 2016 Feb 27;8:15. doi: 10.1186/s13098-016-0131-y. eCollection 2016.

34.

Core regulatory components of the PHO pathway are conserved in the methylotrophic yeast Hansenula polymorpha.

Zhou Y, Yuikawa N, Nakatsuka H, Maekawa H, Harashima S, Nakanishi Y, Kaneko Y.

Curr Genet. 2016 Aug;62(3):595-605. doi: 10.1007/s00294-016-0565-7. Epub 2016 Jan 21.

35.

Improved stress resistance and ethanol production by segmental haploidization of the diploid genome in Saccharomyces cerevisiae.

Kaboli S, Miyamoto T, Sunada K, Sasano Y, Sugiyama M, Harashima S.

J Biosci Bioeng. 2016 Jun;121(6):638-644. doi: 10.1016/j.jbiosc.2015.10.012. Epub 2015 Dec 12.

PMID:
26690924
36.

Carbohydrate intake is associated with time spent in the euglycemic range in patients with type 1 diabetes.

Ayano-Takahara S, Ikeda K, Fujimoto S, Asai K, Oguri Y, Harashima S, Tsuji H, Shide K, Inagaki N.

J Diabetes Investig. 2015 Nov;6(6):678-86. doi: 10.1111/jdi.12360. Epub 2015 May 19.

37.

Once Daily Self-Monitoring of Blood Glucose (SMBG) Improves Glycemic Control in Oral Hypoglycemic Agents (OHA)-Treated Diabetes: SMBG-OHA Follow-Up Study.

Harashima S, Nishimura A, Ikeda K, Wang Y, Liu Y, Inagaki N.

J Diabetes Sci Technol. 2015 Oct 1;10(2):378-82. doi: 10.1177/1932296815608869.

38.

Genome-wide construction of a series of designed segmental aneuploids in Saccharomyces cerevisiae.

Natesuntorn W, Iwami K, Matsubara Y, Sasano Y, Sugiyama M, Kaneko Y, Harashima S.

Sci Rep. 2015 Jul 30;5:12510. doi: 10.1038/srep12510.

39.

DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.

Obara A, Fujita Y, Abudukadier A, Fukushima T, Oguri Y, Ogura M, Harashima S, Hosokawa M, Inagaki N.

Biochem Biophys Res Commun. 2015 May 15;460(4):1047-52. doi: 10.1016/j.bbrc.2015.03.148. Epub 2015 Apr 3.

PMID:
25843797
40.

[DPP-4 inhibitor].

Harashima S, Inagaki N.

Nihon Rinsho. 2015 Mar;73(3):425-31. Japanese.

PMID:
25812368
41.

Nuclear localization domains of GATA activator Gln3 are required for transcription of target genes through dephosphorylation in Saccharomyces cerevisiae.

Numamoto M, Tagami S, Ueda Y, Imabeppu Y, Sasano Y, Sugiyama M, Maekawa H, Harashima S.

J Biosci Bioeng. 2015 Aug;120(2):121-7. doi: 10.1016/j.jbiosc.2014.12.017. Epub 2015 Jan 29.

PMID:
25641578
42.

Glycemic variability is associated with quality of life and treatment satisfaction in patients with type 1 diabetes.

Ayano-Takahara S, Ikeda K, Fujimoto S, Hamasaki A, Harashima S, Toyoda K, Fujita Y, Nagashima K, Tanaka D, Inagaki N.

Diabetes Care. 2015 Jan;38(1):e1-2. doi: 10.2337/dc14-1801. No abstract available.

PMID:
25538320
43.

Stabilization of mini-chromosome segregation during mitotic growth by overexpression of YCR041W and its application to chromosome engineering in Saccharomyces cerevisiae.

Sasano Y, Yamagishi K, Tanikawa M, Nakazawa T, Sugiyama M, Kaneko Y, Harashima S.

J Biosci Bioeng. 2015 May;119(5):526-31. doi: 10.1016/j.jbiosc.2014.10.006. Epub 2014 Nov 15.

PMID:
25454064
44.

Type 2C protein phosphatase Ptc6 participates in activation of the Slt2-mediated cell wall integrity pathway in Saccharomyces cerevisiae.

Sharmin D, Sasano Y, Sugiyama M, Harashima S.

J Biosci Bioeng. 2015 Apr;119(4):392-8. doi: 10.1016/j.jbiosc.2014.09.013. Epub 2014 Nov 10.

PMID:
25449759
45.

Social orientation and diabetes-related distress in Japanese and American patients with type 2 diabetes.

Ikeda K, Fujimoto S, Morling B, Ayano-Takahara S, Carroll AE, Harashima S, Uchida Y, Inagaki N.

PLoS One. 2014 Oct 15;9(10):e109323. doi: 10.1371/journal.pone.0109323. eCollection 2014.

46.

The protein phosphatase Siw14 controls caffeine-induced nuclear localization and phosphorylation of Gln3 via the type 2A protein phosphatases Pph21 and Pph22 in Saccharomyces cerevisiae.

Numamoto M, Sasano Y, Hirasaki M, Sugiyama M, Maekawa H, Harashima S.

J Biochem. 2015 Jan;157(1):53-64. doi: 10.1093/jb/mvu055. Epub 2014 Oct 13.

PMID:
25313402
47.

Restless legs syndrome in patients with type 2 diabetes: effectiveness of pramipexole therapy.

Harashima S, Nishimura A, Osugi T, Wang Y, Liu Y, Takayama H, Inagaki N.

BMJ Support Palliat Care. 2016 Mar;6(1):89-93. doi: 10.1136/bmjspcare-2014-000691. Epub 2014 Sep 12.

PMID:
25216659
48.

Genome-wide mapping of unexplored essential regions in the Saccharomyces cerevisiae genome: evidence for hidden synthetic lethal combinations in a genetic interaction network.

Kaboli S, Yamakawa T, Sunada K, Takagaki T, Sasano Y, Sugiyama M, Kaneko Y, Harashima S.

Nucleic Acids Res. 2014 Sep;42(15):9838-53. doi: 10.1093/nar/gku576. Epub 2014 Aug 7.

49.

Effects of deletion of different PP2C protein phosphatase genes on stress responses in Saccharomyces cerevisiae.

Sharmin D, Sasano Y, Sugiyama M, Harashima S.

Yeast. 2014 Oct;31(10):393-409. doi: 10.1002/yea.3032. Epub 2014 Sep 3.

50.

Nuclear localization of Haa1, which is linked to its phosphorylation status, mediates lactic acid tolerance in Saccharomyces cerevisiae.

Sugiyama M, Akase SP, Nakanishi R, Horie H, Kaneko Y, Harashima S.

Appl Environ Microbiol. 2014 Jun;80(11):3488-95. doi: 10.1128/AEM.04241-13. Epub 2014 Mar 28.

Supplemental Content

Loading ...
Support Center